Zydus Cadila Gets USFDA Nod to Market Ointment for Treating Skin Conditions

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Betamethasone Dipropionate ointment USP 0.05 per cent, Zydus Cadila said in a statement.

from Top Business News- News18.com https://ift.tt/2ZrBsWG

• Tweet
• Share
• Share
• Share
• Share